Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Search Results to Elaine Tat Lam

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Lam, Elaine

Item TypeName
Academic Article Phase I trial of non-cytotoxic suramin as a modulator of docetaxel and gemcitabine therapy in previously treated patients with non-small cell lung cancer.
Academic Article Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer.
Academic Article Axitinib, a new therapeutic option in renal cell carcinoma.
Academic Article Tivozanib: practical implications for renal cell carcinoma and other solid tumors.
Concept Carcinoma, Non-Small-Cell Lung
Concept Carcinoma, Papillary
Concept Carcinoma, Renal Cell
Concept Carcinoma, Transitional Cell
Concept Carcinoma, Medullary
Academic Article Collision renal cell papillary and medullary carcinoma in a 66-year-old man.
Academic Article A phase I study of high-dose interleukin-2 with sorafenib in patients with metastatic renal cell carcinoma and melanoma.
Academic Article Retrospective analysis of the safety and efficacy of high-dose interleukin-2 after prior tyrosine kinase inhibitor therapy in patients with advanced renal cell carcinoma.
Academic Article Kidney cancer, version 3.2015.
Academic Article Local Control Rates of Metastatic Renal Cell Carcinoma (RCC) to Thoracic, Abdominal, and Soft Tissue Lesions Using Stereotactic Body Radiotherapy (SBRT).
Academic Article Local control rates of metastatic renal cell carcinoma (RCC) to the bone using stereotactic body radiation therapy: Is RCC truly radioresistant?
Academic Article A Patient With Newly Diagnosed Metastatic Type 2 Papillary Renal Cell Carcinoma.
Academic Article Does the Renal Parenchyma Adjacent to the Tumor Contribute to Kidney Function? A Critical Analysis of Glomerular Viability in Partial Nephrectomy Specimens.
Academic Article Oncolytic reovirus in combination with chemotherapy in metastatic or recurrent non-small cell lung cancer patients with KRAS-activated tumors.
Academic Article Clinical significance of sunitinib-associated macrocytosis in metastatic renal cell carcinoma.
Academic Article Phase I Dose-Escalation Trial of PT2385, a First-in-Class Hypoxia-Inducible Factor-2a Antagonist in Patients With Previously Treated Advanced Clear Cell Renal Cell Carcinoma.
Academic Article Renal cell carcinoma: a review of biology and pathophysiology.
Academic Article Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study.
Academic Article NCCN Guidelines Insights: Kidney Cancer, Version 2.2020.
Academic Article Patient-Reported Outcomes from the Phase III Randomized IMmotion151 Trial: Atezolizumab + Bevacizumab versus Sunitinib in Treatment-Na?ve Metastatic Renal Cell Carcinoma.
Academic Article Patient-reported outcomes in a phase 2 study comparing atezolizumab alone or with bevacizumab vs sunitinib in previously untreated metastatic renal cell carcinoma.
Academic Article Immune-Related Adverse Events Involving Multiple Organ Sites in a Patient Treated With Nivolumab Plus Ipilimumab.
Academic Article Safety and Efficacy of Nivolumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study.
Academic Article NCCN Guidelines Insights: Kidney Cancer, Version 1.2021.
Academic Article A Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab Versus Pembrolizumab Plus Axitinib and Versus Avelumab Plus Axitinib in First-Line Treatment of Advanced Renal Cell Carcinoma.
Academic Article Tumor flare of brain metastases upon dose interruption of sunitinib in a patient with metastatic renal cell carcinoma.
Academic Article Do we need skin toxicity? Association of immune checkpoint inhibitor and tyrosine kinase inhibitor-related cutaneous adverse events with outcomes in metastatic renal cell carcinoma.
Academic Article Clinical Activity and Safety of Cabozantinib for Brain Metastases in Patients With Renal Cell Carcinoma.
Academic Article Association of Neutrophil-to-Lymphocyte Ratio with Efficacy of First-Line Avelumab plus Axitinib vs. Sunitinib in Patients with Advanced Renal Cell Carcinoma Enrolled in the Phase 3 JAVELIN Renal 101 Trial.
Academic Article Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
Academic Article Biomarker-Based Phase II Study of Sapanisertib (TAK-228): An mTORC1/2 Inhibitor in Patients With Refractory Metastatic Renal Cell Carcinoma.
Academic Article Metastatic Renal Cell Carcinoma With Sarcomatoid Features.
Academic Article Role of Clock Genes and Circadian Rhythm in Renal Cell Carcinoma: Recent Evidence and Therapeutic Consequences.
Academic Article Metastatic renal cell carcinoma to the pancreas and other sites-a multicenter retrospective study.
Academic Article A Phase I/II Clinical Trial of Pembrolizumab and Cabozantinib in Metastatic Renal Cell Carcinoma.
Academic Article Pathological Outcomes of Patients With Advanced Renal Cell Carcinoma Who Receive Nephrectomy Following Immunotherapy.
Academic Article Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study.
Academic Article Outcomes of Consolidative Nephrectomy following Primary Immunotherapy in Advanced Renal Cell Carcinoma: A Multicenter Analysis.
Academic Article Bone targeting agents, but not radiation therapy, improves survival in patients with bone metastases from advanced urothelial carcinoma receiving pembrolizumab: results from the ARON-2 study.
Academic Article Impact of healthcare inequities on survival in Mexican patients with metastatic renal cell carcinoma.

Search Criteria
  • Carcinoma

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)